Erasca Inc. Common Stock vs Rex Fang & Innovation Equity Premium Income ETF — how do they compare? Erasca Inc. Common Stock trades at $15.97 (market cap $5.40B), while Rex Fang & Innovation Equity Premium Income ETF trades at $43.51 (market cap $746.48M). The key difference: Erasca Inc. Common Stock is far larger — about 7.2× Rex Fang & Innovation Equity Premium Income ETF's market cap, and Erasca Inc. Common Stock is trading nearer its 52-week high, Rex Fang & Innovation Equity Premium Income ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Erasca Inc. Common Stock for 0 Days and Rex Fang & Innovation Equity Premium Income ETF for 56 Days on average.
| ERAS | FEPI | |
|---|---|---|
Market Cap | $5.40B | $746.48M |
Volume | 9,533,185 | 334,337 |
Sector | Health | Income / Options Overlay |
52-Week High | $22.47 | $49.54 |
52-Week Low | $2.20 | $37.98 |
Typical Hold Time | 0 Days | 56 Days |
Enterprise Value | $5.18B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
FEPI (REX FANG & Innovation Equity Premium Income ETF) trades at $43.51, down 0.18% with a bullish technical signal from moving averages. The ETF employs a covered call strategy on concentrated AI and mega-cap tech holdings, generating high weekly distributions averaging $0.20-0.21. Recent articles highlight its 25% trailing yield but note capped upside potential and underperformance versus peers in total return during tech rallies.
The outlook balances high income generation against significant risk from tech concentration and volatility dependence. While the covered call strategy funds substantial dividends, it limits capital appreciation during market upswings. Key risks include drawdown vulnerability if tech stocks decline and competitive pressure from higher-performing income alternatives. Analyst sentiment remains cautious due to the trade-off between yield and total return potential.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Erasca is a biotechnology company developing precision medicines for cancer. Its programs target genetic drivers of tumor growth.
Read more on ERAS →FEPI provides exposure to top innovation stocks while generating monthly income. It uses a covered call strategy on high-volatility tech stocks to capture option premiums for investors.
Read more on FEPI →